Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3479383 | Journal of the Formosan Medical Association | 2012 | 6 Pages |
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immune tolerance to self antigens and by the persistent production of pathogenic autoantibodies. Recent studies have suggested a dysregulation of regulatory T-cells (Tregs), particularly CD4+CD25highFoxP3+ (forkhead box P3) Tregs, as one of the major factors conferring the risk for expression of human autoimmune diseases, including SLE. However, detailed studies of CD4+FoxP3+ T-cells in patients with SLE remain limited. We attempt here to integrate the current experimental evidence to delineate the role of CD4+CD25high and other subsets of CD4+FoxP3+ T-cells in human SLE.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jau-Ling Suen, Bor-Luen Chiang,